D Skinner1, A C Hesseling2, C Francis2, A M Mandalakas3. 1. Research on Health and Society, Faculty of Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa. 2. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, Cape Town, South Africa. 3. Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, Cape Town, South Africa ; Section on Retrovirology and Global Health, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA ; The TB Initiative, Texas Children's Hospital, Houston, Texas, USA.
Abstract
SETTING: Isoniazid preventive therapy (IPT) offers children protection against tuberculosis (TB), but it has been difficult to implement, particularly in developing countries. OBJECTIVE: To understand what encourages or inhibits children from adhering to IPT. DESIGN: In-depth interviews were conducted with two parents of children adherent to IPT and two staff members from three primary health care clinics in high TB prevalence communities. Themes explored were knowledge and attitudes towards IPT, problems in accessing and adhering to treatment, and community responses. RESULTS: Parents administering treatment valued it positively, realised their children's risk of TB, and were positive about the clinic. Nurses acknowledged that resistance to treatment remained, with some parents not wanting to acknowledge risk nor willing to make the effort for their children; there was also considerable misinformation about IPT. Clinic nurses acknowledged problems of staff shortages, lengthy waiting times and conflict between staff and community members. Adherence was affected by social problems, stigma about TB and its link to the human immunodeficiency virus, and the extended treatment period. CONCLUSION: Parents who maintained adherence to the IPT regimen showed that it was possible even in very difficult circumstances. Further effort is required to improve some of the clinic services, correct misinformation, reduce stigma and provide support to parents.
SETTING:Isoniazid preventive therapy (IPT) offers children protection against tuberculosis (TB), but it has been difficult to implement, particularly in developing countries. OBJECTIVE: To understand what encourages or inhibits children from adhering to IPT. DESIGN: In-depth interviews were conducted with two parents of children adherent to IPT and two staff members from three primary health care clinics in high TB prevalence communities. Themes explored were knowledge and attitudes towards IPT, problems in accessing and adhering to treatment, and community responses. RESULTS: Parents administering treatment valued it positively, realised their children's risk of TB, and were positive about the clinic. Nurses acknowledged that resistance to treatment remained, with some parents not wanting to acknowledge risk nor willing to make the effort for their children; there was also considerable misinformation about IPT. Clinic nurses acknowledged problems of staff shortages, lengthy waiting times and conflict between staff and community members. Adherence was affected by social problems, stigma about TB and its link to the human immunodeficiency virus, and the extended treatment period. CONCLUSION: Parents who maintained adherence to the IPT regimen showed that it was possible even in very difficult circumstances. Further effort is required to improve some of the clinic services, correct misinformation, reduce stigma and provide support to parents.
Authors: A M Mandalakas; H L Kirchner; C Lombard; G Walzl; H M S Grewal; R P Gie; A C Hesseling Journal: Int J Tuberc Lung Dis Date: 2012-06-11 Impact factor: 2.373
Authors: Linde Scholten; Agnes M Willemen; Bob F Last; Heleen Maurice-Stam; Elisabeth M van Dijk; Elske Ensink; Noortje Zandbelt; Aafke van der Hoop-Mooij; Carlo Schuengel; Martha A Grootenhuis Journal: Pediatrics Date: 2013-03-11 Impact factor: 7.124
Authors: B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers Journal: Int J Tuberc Lung Dis Date: 2004-04 Impact factor: 2.373
Authors: Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye Journal: Arch Intern Med Date: 2003-05-12
Authors: Merrin E Rutherford; Philip C Hill; Rina Triasih; Rebecca Sinfield; Reinout van Crevel; Stephen M Graham Journal: Trop Med Int Health Date: 2012-08-05 Impact factor: 2.622
Authors: H Simon Schaaf; Ben J Marais; Andrew Whitelaw; Anneke C Hesseling; Brian Eley; Gregory D Hussey; Peter R Donald Journal: BMC Infect Dis Date: 2007-11-29 Impact factor: 3.090
Authors: Dillon T Wademan; Graeme Hoddinott; Susan E Purchase; James A Seddon; Anneke C Hesseling; Anthony J Garcia-Prats; Ria Reis; Lindsey J Reynolds Journal: PLoS One Date: 2022-07-14 Impact factor: 3.752
Authors: Amrita Daftary; Ellen M H Mitchell; Michael J A Reid; Endalkachew Fekadu; Eric Goosby Journal: Am J Trop Med Hyg Date: 2018-11 Impact factor: 2.345
Authors: U Egere; A Sillah; T Togun; S Kandeh; F Cole; A Jallow; A Able-Thomas; M Hoelscher; N Heinrich; P C Hill; B Kampmann Journal: Public Health Action Date: 2016-12-21
Authors: Daria Szkwarko; Yael Hirsch-Moverman; Lienki Du Plessis; Karen Du Preez; Catherine Carr; Anna M Mandalakas Journal: PLoS One Date: 2017-08-01 Impact factor: 3.240